Alcidion Group (ASX:ALC) has signed its first contract in Wales with Hywel Dda University Health Board for use of its Miya Precision Platform – inclusive of Miya Precision for Patient Flow, Observations and Assessments and Smartpage.
The Total Contract Value (TCV) is $5.5 million over a term of five years, with an option to extend to seven years, increasing the TCV to $7.7 million. The agreement is structured as an annually recurring subscription licence.
Hywel Dda University Health Board in Wales plans to deploy the Miya Precision platform to uphold a whole of system approach to managing patient information, supporting goals outlined by the Welsh Government.
This is anticipated to lead to improved population health and wellbeing; better quality and more accessible care services; higher value health and social care; and an improved experience for staff.
This is the first contract for Alcidion with a Health Board in Wales and comes at an exciting time for Wales as they look to increase digital maturity across the country.
The cloud-hosted, web-based Miya Precision Patient Flow, Observations and Assessment and Smartpage capabilities will support the Health Board’s care delivery across various services, including real-time patient flow management and alerting users to deteriorating patients.
Hywel Dda University Health Board provides primary, secondary and community and dental health services to around 380,000 people in west Wales. It is responsible for four acute hospitals, five community hospitals, two integrated care centres in addition to general practices, dental practices, community pharmacies, ophthalmic practices, and care in individuals’ own homes.
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients,” Alcidion CEO and MD, Kate Quirke, said.
“Won in a competitive tender process, this is the first contract we have secured with a Health Board in Wales, which is a deeply established and respected model of tertiary healthcare in the Northern Hemisphere. We are honoured to support the Health Board on their important 10-year journey of digital transformation.”
